Form 4: ATI Physical Therapy Director Awarded Stock Options
SEC Form 4
Teresa Sparks, a director at ATI Physical Therapy, was granted several stock options on August 20, 2024, with varying exercise prices and vesting schedules.
Summary
- Teresa Sparks, a director of ATI Physical Therapy, received stock options on August 20, 2024.
- The options are for Class A Common Stock and have exercise prices ranging from $10 to $50.
- The options vest in three equal installments on April 1, 2025, April 1, 2026, and April 1, 2027, contingent upon continued service.
- Sparks also holds previously granted stock options from December 28, 2021, and March 7, 2022, which have been adjusted for a reverse stock split.
- These earlier options also vest in three annual installments from their respective grant dates.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It reports a standard compensation practice (stock option grant) and doesn't inherently indicate positive or negative sentiment.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule encourages continued service and commitment from the director.
Risks
- The value of the stock options is dependent on the future performance of ATI Physical Therapy's stock price.
- If the stock price does not exceed the exercise prices, the options will be worthless.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's financial performance or future prospects, only the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, aligning the interests of directors and management with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for directors in publicly traded companies.
- The vesting schedules are typical, designed to incentivize long-term commitment.
- Without further information on the size of the grant relative to the company's market capitalization and the director's overall compensation, it's difficult to assess whether the grant is in line with industry benchmarks.
Stakeholder Impact
- The stock option grant could potentially benefit shareholders if the director's performance leads to an increase in the company's stock price.
- The grant incentivizes the director to act in the best interests of the company and its shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/28/2021 | Date of previous stock option grant, adjusted for reverse stock split. |
| 03/07/2022 | Date of previous stock option grant, adjusted for reverse stock split. |
| 06/14/2023 | Date of reverse stock split. |
| 08/20/2024 | Date of the current stock option grant. |
| 04/01/2025 | First vesting date for one-third of the newly granted stock options. |
| 04/01/2026 | Second vesting date for one-third of the newly granted stock options. |
| 04/01/2027 | Final vesting date for one-third of the newly granted stock options. |
| 08/20/2034 | Expiration date of the newly granted stock options. |
Keywords
stock options, director, ATI Physical Therapy, ATIP, Teresa Sparks, beneficial ownership, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.